Injectable Skin Boosters
A real, measurable improvement in skin hydration and fine texture that fades on a predictable schedule.
Last reviewed 15 September 2026
The brand on the syringe is the least useful thing about a filler treatment. What decides how it looks, how long it lasts and whether it can be undone is which region it went into and which layer it was placed in. Here is the map.
Almost every consultation about filler starts with a brand name. Someone read about a product, or a friend had it, or a clinic advertises it. I understand why. The brand is the only part of the treatment that gets marketed to you.
It is also the part that changes the result least.
Two people can be injected with the identical gel from the identical box and walk out looking completely different, because one had it placed deep on the cheekbone and the other had it placed superficially under the eye. Same molecule. Different plane, different region, different treatment. If you learn one thing before you sit in an injector's chair, learn to ask where the product is going and how deep.
Filler sits in a layer, and each layer behaves differently.
Placed deep, on bone, a stiff gel acts as structure. It supports the tissue above it, it moves very little, and it holds its shape when you smile. Placed superficially, in or just under the skin, the same material has to bend every time your face moves, and it shows through thin skin as a shadow or a blue-gray cast.
That is why the honest version of the filler conversation is anatomical. The useful question is not which product you want. It is which region has actually lost support, and which layer that support belongs in.
The map above is the working version of what I sketch on paper in the room. Eight regions, each with its own plane, its own realistic longevity, and its own way of going wrong.
A few things worth pulling out of it.
The lateral cheek does the most work. Product placed deep on the zygomatic bone supports the whole midface. It is often the region that fixes a complaint about somewhere else entirely: the nasolabial fold, the under-eye, the jawline. Those are shadows cast by a midface that has descended and deflated.
The tear trough is the least forgiving region on the face. Skin there is thinner than anywhere else, the product binds water, and the margin between a correction and a permanent puffiness is small. It is also the region where product persists longest. I have dissolved filler placed under someone's eyes five years earlier.
The nasolabial fold is usually a symptom. The fold deepens because the cheek above it fell. Filling the fold treats the shadow and leaves the cause alone, which is why the result so often reads as heavy.
Filler defines a jawline. It does not lift a jowl. Past a certain amount of laxity, product along the mandible makes the jowl more conspicuous, because you have drawn a hard line underneath it.
Gels are described by how much force it takes to deform them. High-stiffness gels hold shape and resist the pressure of the tissue above them, which is what you want on bone. Low-stiffness gels spread and move, which is what you want in a lip.
Neither is better. A stiff gel in a lip looks like a sausage. A soft gel on a cheekbone disappears into the tissue and does nothing, and then someone recommends more syringes.
The same logic covers biostimulators — poly-L-lactic acid, dilute calcium hydroxylapatite. Those are not fillers in the ordinary sense. They deposit a material your body responds to by making collagen, so the result arrives over months and leaves over years. That is a genuinely different treatment with a genuinely different risk profile, and it belongs in a different conversation from a hyaluronic acid gel.
Hyaluronic acid dissolves. Hyaluronidase breaks it down within a day or two, and that is a meaningful safety feature — it is what makes a vascular complication treatable, and it is why I use HA in the regions where the consequences of getting it wrong are highest.
Two caveats.
Dissolving is not free. Hyaluronidase is not perfectly selective, and the tissue takes weeks to settle afterward. Nobody should treat reversibility as a license to over-treat and undo it later.
And calcium hydroxylapatite and poly-L-lactic acid do not dissolve. If you are having a biostimulator placed in your jawline or your chin, you are making a decision you cannot take back for a year or more. That is not an argument against them. It is an argument for placing them conservatively.
This is the part that is hardest to find written down, so here it is plainly. Each region fails in its own characteristic way.
None of these happen in one appointment. They happen over years, half a syringe at a time, and they happen because each individual appointment was defensible on its own.
I sort a face into three questions before anyone touches a syringe.
What has descended? That is a lifting problem, and product does not answer it.
What has deflated? That is a volume problem, and where it is deflated tells me which plane the volume belongs in.
What is simply the shape of your face? Some of what people want to fill is anatomy, not aging, and filling it changes who you look like.
Most faces are a mix of all three in a proportion specific to that face. Sorting out which is which is the entire value of a consultation, and it is why a plan that starts with a product name has the sequence backwards.
Four, and they take a minute.
The fourth one is the most useful question on the list. An injector who has a clear answer to it is thinking about your face over a decade. An injector who treats everything you point at is thinking about today.
A real, measurable improvement in skin hydration and fine texture that fades on a predictable schedule.
Last reviewed 15 September 2026
A small, short-lived repositioning effect that is consistently oversold as an alternative to surgery.
Last reviewed 15 September 2026
A prospective multicenter study in the Aesthetic Surgery Journal followed patients treated with a next-generation poly-L-lactic acid biostimulator in the nasolabial folds for a year, reporting effectiveness, satisfaction and safety. Biostimulators are a different treatment from hyaluronic acid rather than a longer-lasting version of it: they deposit a material the body answers by making collagen, so the result builds over months and fades over years. Durability data therefore matters more here than it does for a gel that dissolves.
Aesthetic surgery journal, “Effectiveness, Patient Satisfaction, and Safety of a Next-generation PLLA Collagen Biostimulator for Nasolabial Fold Augmentation: 12-month Results of a Prospective Multicenter Study.” — read the original
A review in the Aesthetic Surgery Journal examined forty-six U.S. civil cases involving injectable fillers between 1967 and 2025. Verdicts split almost evenly overall, and autologous fat, hyaluronic acid and biostimulators were implicated in roughly equal numbers. Two findings stand out: cases arising from med-spa procedures produced a plaintiff verdict every time, against forty-seven percent in private clinics and hospitals, and cases involving products without regulatory approval did the same. Neither the injector's credentials nor the severity of the complication predicted the outcome on its own.
Aesthetic surgery journal, “Litigating Filler Complications: Five Decades of Legal Outcomes in the United States.” — read the original
The medication is not damaging your face. Fast weight loss is, and it does it through discrete fat compartments that empty at different rates. That mechanism decides which treatments can realistically restore it.
Last reviewed 15 September 2026
Both operations are called facelifts and both are done by good surgeons. The difference is which anatomical layer carries the lift, and that one decision changes the look, the durability, the scar and the risk profile.
Last reviewed 15 September 2026
Newsletter
What changed in facial rejuvenation this week, one guide we updated, and why it matters. Written by Jay Keni, MD.